Is There a Link Between Progressive Supranuclear Palsy and Bullous Pemphigoid?
作者信息
Han Winn Hui, Yong Shin Shen, Kwan Zhenli, Lim Shen-Yang
机构信息
Division of Dermatology, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Division of Neurology, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
出版信息
J Mov Disord. 2025 Jul;18(3):271-273. doi: 10.14802/jmd.25019. Epub 2025 Apr 8.
Abstract
摘要
相似文献
1
Is There a Link Between Progressive Supranuclear Palsy and Bullous Pemphigoid?
J Mov Disord. 2025 Jul;18(3):271-273. doi: 10.14802/jmd.25019. Epub 2025 Apr 8.
2
Associations between neuropsychological profile and regional brain FDG uptake in progressive supranuclear palsy.
J Parkinsons Dis. 2025 Jun;15(4):904-912. doi: 10.1177/1877718X251343080. Epub 2025 May 25.
3
Interventions for bullous pemphigoid.
Cochrane Database Syst Rev. 2023 Aug 11;8(8):CD002292. doi: 10.1002/14651858.CD002292.pub4.
4
Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
Am J Clin Dermatol. 2004;5(5):319-26. doi: 10.2165/00128071-200405050-00005.
5
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.
Lancet Neurol. 2025 Jul;24(7):580-590. doi: 10.1016/S1474-4422(25)00157-7.
6
A systematic review of treatments for bullous pemphigoid.
Arch Dermatol. 2002 Mar;138(3):385-9. doi: 10.1001/archderm.138.3.385.
7
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
8
Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsy.
Alzheimers Dement. 2024 Dec;20(12):8294-8307. doi: 10.1002/alz.14249. Epub 2024 Oct 22.
9
Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Indian J Dermatol Venereol Leprol. 2018 Jan-Feb;84(1):22-26. doi: 10.4103/ijdvl.IJDVL_827_16.
10
Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review.
JBI Database System Rev Implement Rep. 2016 Jun;14(6):148-95. doi: 10.11124/JBISRIR-2016-2002352.
本文引用的文献
1
Four-Repeat Tau Seeding in the Skin of Patients With Progressive Supranuclear Palsy.
JAMA Neurol. 2024 Sep 23;81(11):1228-30. doi: 10.1001/jamaneurol.2024.3162.
2
Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia.
Mov Disord. 2024 Oct;39(10):1829-1842. doi: 10.1002/mds.29932. Epub 2024 Aug 16.
3
Bullous Pemphigoid Associated with Multiple System Atrophy: Case Series.
Mov Disord Clin Pract. 2021 Feb 25;8(3):445-448. doi: 10.1002/mdc3.13160. eCollection 2021 Apr.
4
Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
JAMA Dermatol. 2020 Aug 1;156(8):891-900. doi: 10.1001/jamadermatol.2020.1587.
5
A multi-hit hypothesis of bullous pemphigoid and associated neurological disease: Is HLA-DQB1*03:01, a potential link between immune privileged antigen exposure and epitope spreading?
HLA. 2017 Mar;89(3):127-134. doi: 10.1111/tan.12960. Epub 2017 Jan 19.
6
The Association Between Bullous Pemphigoid and Neurological Disorders in A Selected Malaysian Population.
Med J Malaysia. 2015 Apr;70(2):81-5.
7
Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain.
Br J Dermatol. 2009 Jun;160(6):1343-5. doi: 10.1111/j.1365-2133.2009.09122.x. Epub 2009 Mar 26.
Zotero 插件